Aimei Health Technology Co., Ltd. Receives Nasdaq Notice Regarding Delayed Annual Report Filing

New York, NY – April 21, 2026 – Aimei Health Technology Co., Ltd. (Nasdaq: AFJK) has announced that it received a formal notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC on April 17, 2026. This notice was issued due to the company’s delay in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

Key Points for Investors

• Non-Compliance Notice: The company is currently not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all periodic financial reports with the U.S. Securities and Exchange Commission (SEC).
• Filing Timeline: The 10-K was due on March 31, 2026. The company filed a Notification of Late Filing (Form 12b-25) on April 1, 2026, but has not yet submitted the Annual Report.
• No Immediate Delisting: At present, this notice does not affect the company’s listing or trading status on Nasdaq. However, the company’s continued listing is contingent on regaining compliance within the prescribed timelines.

Critical Information for Shareholders

• Potential Delisting Risk: If the company does not file the delayed Annual Report or submit a sufficient plan to Nasdaq within 60 calendar days from the date of the notice (received April 17, 2026), its securities could be subject to delisting.
• Extension Possibility: If a compliance plan is accepted by Nasdaq, the company may receive up to 180 calendar days from the original due date (March 31, 2026) to regain full compliance.
• Right to Appeal: Should Nasdaq reject the company’s compliance plan, Aimei Health Technology will have the opportunity to appeal the decision before a Nasdaq hearings panel.
• Management Action: The company has stated it is working diligently to complete and file the Annual Report as soon as possible and expects to regain compliance.
• Regulatory Disclosure: This announcement is made in accordance with Nasdaq Listing Rule 5810(b), which requires companies to promptly disclose receipt of a deficiency notification.

About Aimei Health Technology Co., Ltd.

Aimei Health Technology is a blank check company, incorporated in the Cayman Islands as an exempted company with limited liability. Its primary purpose is to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. While the company’s search for a target is not limited to any specific industry or geography, it intends to focus on healthcare innovation.

Forward-Looking Statements

The press release contains forward-looking statements based on management’s current expectations and assumptions. These statements are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied. The company undertakes no obligation to update these statements, except as required by law.

Investor and Media Contact

Aimei Health Technology Co., Ltd.
10 East 53rd Street, Suite 3001
New York, NY 10022
Attention: Junheng Xie
Email: [email protected]

Disclaimer: This article is intended for informational purposes only and does not constitute investment advice. Investors should consider all publicly available information and consult with their financial advisors before making any investment decisions. The information provided herein reflects the company’s status as of the date of the press release and may be subject to change.

View Aimei Health Technology Co., Ltd. Historical chart here